These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Critical appraisal of current antithrombotic trials in patients undergoing total hip replacement. Kher A Expert Opin Investig Drugs; 2001 Dec; 10(12):2175-83. PubMed ID: 11772313 [TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis. Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711 [TBL] [Abstract][Full Text] [Related]
6. [Perioperative venous thromboembolism prophylaxis: short review and recommendations]. Samama CM Ann Fr Anesth Reanim; 2008 Dec; 27 Suppl 3():S2-8. PubMed ID: 19185783 [TBL] [Abstract][Full Text] [Related]
7. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement. Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569 [TBL] [Abstract][Full Text] [Related]
9. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280 [TBL] [Abstract][Full Text] [Related]
10. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group. Kakkar VV; Howes J; Sharma V; Kadziola Z Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310 [TBL] [Abstract][Full Text] [Related]
11. [Treatment and prophylaxis of deep venous thrombosis with low molecular weight heparins (meta-analysis of clinical trials)]. Valiukiene L; Naudziūnas A; Unikauskas A Medicina (Kaunas); 2003; 39(4):352-8. PubMed ID: 12738903 [TBL] [Abstract][Full Text] [Related]
13. [Venous thromboembolic disease in general surgery]. Arcelus Martínez JI Med Clin (Barc); 2008 Nov; 131 Suppl 2():29-36. PubMed ID: 19087848 [TBL] [Abstract][Full Text] [Related]
14. Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery. Raskob GE; Hirsh J Chest; 2003 Dec; 124(6 Suppl):379S-385S. PubMed ID: 14668421 [TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307 [TBL] [Abstract][Full Text] [Related]
16. Tinzaparin sodium: a review of its pharmacology and clinical use in the prophylaxis and treatment of thromboembolic disease. Cheer SM; Dunn CJ; Foster R Drugs; 2004; 64(13):1479-502. PubMed ID: 15212562 [TBL] [Abstract][Full Text] [Related]
17. Duplex screening as a method of quality assurance of perioperative thromboembolism prophylaxis. Van Den Berg E; Bathgate B; Panagakos E; Lambrechts R; Hani M; Meissner A; Schröder M Int Angiol; 1999 Sep; 18(3):210-9. PubMed ID: 10688420 [TBL] [Abstract][Full Text] [Related]
18. Clinical experience with ximelagatran in orthopaedic surgery. Eriksson B Drugs; 2004; 64 Suppl 1():27-35. PubMed ID: 15586625 [TBL] [Abstract][Full Text] [Related]